Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Alphamab Oncology Completed Enrollment in the First Pivotal Phase III Clinical Study of the Bispecific Antibody KN046 2021-10-18 10:19
Dole Sunshine Company Partners With EDB New Ventures To Create A New Business In Specialty Ingredients Developed From Fruit Side-streams 2021-10-18 09:00
UPL Announces Long-term Collaboration With Chr. Hansen To Develop And Commercialize Microbial Solutions For Sustainable Agriculture 2021-10-16 05:04
Novavax to Participate in World Vaccine Congress Europe 2021-10-16 04:39
CellOrigin secured a new round of investment for developing its globally proprietary iPSC-CAR-Macrophage technology platform 2021-10-15 20:50
Antengene to Present Data of Its PD-L1/4-1BB Bispecific Antibody ATG-101 and ERK1/2 Inhibitor ATG-017 at SITC 2021 2021-10-15 13:33
International Biopharma Industry Week Shanghai 2021 Opens 2021-10-15 12:22
Qiming's Portfolio Company Abbisko Lists on Main Board of HKEx 2021-10-15 12:00
GV20 Oncotherapy Completes Series B Financing to Advance Pipeline into the Clinic and Expand Immuno-Oncology Drug Discovery Platform 2021-10-14 23:55
Gan & Lee Pharmaceuticals Concludes Phase 3 Studies of Gan & Lee Insulin Glargine (GL-GLA) 2021-10-14 20:46
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with Its AI Immunology Platforms 2021-10-14 19:30
BioAgilytix Closes Acquisition of Australia-based 360biolabs® 2021-10-14 19:00
BioAgilytix Closes Acquisition of Australia-based 360biolabs® 2021-10-14 19:00
One-shot Sputnik Light vaccine (first component of the Sputnik V vaccine) demonstrates 70% efficacy against infection with the Delta variant during the first three months after vaccination, Gamaleya Center analysis shows 2021-10-13 20:30
I-Mab Advances Late-stage Development of Its Differentiated CD38 Antibody Felzartamab (TJ202) in China 2021-10-13 20:00
Gilead Sciences Partners with the International AIDS Society to Champion Stigma-free HIV Care Services in Asia and Latin America 2021-10-13 13:00
AUM Biosciences announces closing of USD $27Million in a "Series A" Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies 2021-10-13 02:30
Vitality International - Pioneering Algorithm Calculates The Number Of Years Individuals Can Expect To Live In Good Health 2021-10-12 22:54
Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene Therapy 2021-10-12 21:00
Emmaus Life Sciences Acquires Key Intellectual Property Rights to Novel IRAK4 Inhibitor From Kainos Medicine 2021-10-12 20:23
1 216 217 218 219 220 452